Tamoxifen in Treating Patients With Primary Liver Cancer
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Estrogen can stimulate the growth of cancer cells. Hormone therapy using tamoxifen
may fight liver cancer by blocking the absorption of estrogen. It is not yet known whether
receiving tamoxifen is more effective than no further therapy in treating patients with
primary liver cancer.
PURPOSE: Randomized phase III trial to compare high-dose tamoxifen with no further treatment
in treating patients with liver cancer that cannot be surgically removed.
Phase:
Phase 3
Details
Lead Sponsor:
National Medical Research Council (NMRC), Singapore